REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
28/06/2025
Voltar para busca
Dado oficial do USPTO
UNISUN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
29/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
40, 42
Data de depósito
03/09/2014
Data de registro
28/06/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/03/2023
Última transação
29/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
28/08/2014
Primeiro uso no comércio
28/08/2014
Código do desenho
4
Tipo de titular
03
Localização do titular
Philadelphia, PA
Examinador
JOHNSON, DONALD
Unidade examinadora
L40
Localização atual
TMEG LAW OFFICE 104
Titulares e representantes
Titulares
Adare Pharmaceuticals Usa, Inc.
Orbis Biosciences, Inc.
Orbis Biosciences, Inc.
Representantes
C. Blair Barbieri HOVEY WILLIAMS LLP
Classificação técnica
Classes Nice
Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Manufacturing services for others in the area of pharmaceutical drug delivery systemsincluding continuous releasepulsatile releaseextended releasesustained releasedelayed release systemsclinical manufacturing of drug formulations for others to support clinical trialsfabrication and preparation of active pharmaceutical ingredients for otherstechnology scale-up services for othersintegration of technology into manufacturing processes for othersall relating to multiple drug product formatssemi-solidssolutionssuspensionsparticulatessolid dispersionssolid solutions and injectablesall for inner ear delivery
Classe 42
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development servicesresearch and development in the area of pharmaceutical drug delivery systemsincluding continuous releasepulsatile releaseextended releasesustained releasedelayed release systemsconsisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredientsanalytic techniques to test drug formulationsanalytic services to detectidentify and quantify drug componentsstability testingphysical characterization of drug formulationsin-vitro release testingall relating to multiple drug product formatssemi-solidssolutionssuspensionsparticulatessolid dispersionssolid solutions and injectablesall for inner ear delivery
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
14/02/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/02/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
27/03/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
27/03/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
15/02/2023
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
04/10/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/10/2022
E815
TEAS SECTION 8 & 15 RECEIVED
06/04/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/06/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
14/10/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
28/06/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
24/05/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23/05/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
21/05/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/05/2016
IUAF
USE AMENDMENT FILED
26/04/2016
EISU
TEAS STATEMENT OF USE RECEIVED
26/04/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/04/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/04/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23/02/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/12/2015
PUBO
PUBLISHED FOR OPPOSITION
29/12/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/12/2015
EXPT
EXPARTE APPEAL TERMINATED
02/11/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/10/2015
EXPI
EX PARTE APPEAL-INSTITUTED
28/10/2015
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
28/10/2015
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
28/10/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/10/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
26/10/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/04/2015
GNFR
FINAL REFUSAL E-MAILED
28/04/2015
CNFR
FINAL REFUSAL WRITTEN
28/04/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/12/2014
GNRT
NON-FINAL ACTION E-MAILED
19/12/2014
CNRT
NON-FINAL ACTION WRITTEN
19/12/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/12/2014
GNRT
NON-FINAL ACTION E-MAILED
16/12/2014
CNRT
NON-FINAL ACTION WRITTEN
16/12/2014
DOCK
ASSIGNED TO EXAMINER
14/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2014
NWAP
NEW APPLICATION ENTERED
06/09/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UNISUN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.